Thromb Haemost 1996; 75(04): 642-647
DOI: 10.1055/s-0038-1650336
Original Article
Schattauer GmbH Stuttgart

Naturally Occurring IgG Autoantibodies to Platelet Cytoskeleton Tropomyosin

Ming Hou
The Hematology Section, Department of Medicine, Sahlgrenska University Hospital, University of Göteborg, Göteborg, Sweden
,
Dick Stockelberg
The Hematology Section, Department of Medicine, Sahlgrenska University Hospital, University of Göteborg, Göteborg, Sweden
,
Jack Kutti
The Hematology Section, Department of Medicine, Sahlgrenska University Hospital, University of Göteborg, Göteborg, Sweden
,
Hans Wadenvik
The Hematology Section, Department of Medicine, Sahlgrenska University Hospital, University of Göteborg, Göteborg, Sweden
› Author Affiliations
Further Information

Publication History

Received 20 April 1995

Accepted after resubmission 11 January 1996

Publication Date:
10 July 2018 (online)

Summary

We have observed that naturally occurring serum antibodies generated a 30 Kd band in a platelet immunoblot assay. The target protein had the same molecular weight (30 Kd) under nonreduced and reduced electrophoretic conditions, and could be immunoblotted from either autologous or homologous platelet lysates. Also, the 30 Kd reactive autoantibodies could be totally adsorbed by platelet cytoskeletons. From these data one likely candidate for the autoantibody target was the intracellular platelet protein tropomyosin. Indeed, a commercially available monoclonal antitropomyosin antibody reacted with proteins comigrating with this 30 Kd band; affinity purified human platelet tropomyosin was bound by the antibodies that recognized the 30 Kd protein. This body of evidence conclusively demonstrated that naturally occurring serum autoantibodies reacted with the platelet cytoskeleton protein - tropomyosin. These tropomyosin specific antibodies were found in roughly the same percentage of sera from patients with chronic idiopathic thrombocytopenic purpura (ITP) as from normal individuals.

 
  • References

  • 1 van Leeuwen EF, van der Ven JTH, Engelfriet CP, von dem Bome AEGK. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood 1982; 59: 23-26
  • 2 Woods VL, Kurata Y, Montgomery RR, Tani P, Mason D, Oh EH, McMillan R. Autoantibodies against platelet glycoprotein lb in patients with chronic immune thrombocytopenic purpura. Blood 1984; 64: 156-160
  • 3 Szatkowski NS, Kunicki TJ, Aster RH. Identification of glycoprotein lb as a target for autoantibody in idiopathic (autoimmune) thrombocytopenic purpura. Blood 1986; 67: 310-315
  • 4 Kiefel V, Santoso S, Kaufmann E, Mueller-Eckhardt C. Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 1991; 79: 256-262
  • 5 Sugiyama T, Okuma M, Ushibuki F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987; 69: 1712-17120
  • 6 Pfueller SL, David R, Firkin BG, Bilston RA, Cortizo WF, Raines G. Platelet aggregating IgG antibody to platelet surface glycoproteins associated with thrombosis and thrombocytopenia. Br J Haematol 1990; 74: 336-341
  • 7 He R, Reid DM, Jones CE, Shulman NR. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood 1994; 83: 1024-1032
  • 8 Kekomaki R, Dawson B, McFarland J, Kunicki TJ. Localisation of human platelet autoantigens to the cystein-rich region of glycoprotein Ha. J Clin Invest 1991; 88: 847-854
  • 9 Morel-Kopp MC, Tchemia G, Lambert T, Verdy E, Schlegel N, Dreyfus M, Chateauvieux L, Kaplan C. Autoantibodies directed against the platelet GP complex Ib-IX in normal individuals. Blood 1992; 80: 49a
  • 10 Denomme GA, Kelton JG, Bell DA. The production of human monoclonal antiplatelet autoantibodies derived from human lymphocytes of normal origin: Reactivity to DNA, anionic phospholipids and platelet proteins. Br J Haematol 1992; 82: 99-106
  • 11 Varon D, Linder S, Gembom E, Guedg L, Langbeheim H, Berrebi A, Eshhar Z. Human monoclonal antibody derived from an autoimmune thrombocytopenic purpura patient, recognizing an intermediate filament’s determinant common to vimentin and desmin. Clin Immunol Immunopath 1990; 54: 454-461
  • 12 Tomiyama Y, Kekomaki R, McFarland J, Kunicki TJ. Antivinculin antibodies in sera of patients with immune thrombocytopenia and normal subjects. Blood 1992; 79: 161-168
  • 13 Reid DM, Jones CE, Luo CY, Shulman NR. Immunoglobulins from normal sera bind platelet vinculin and talin and their proteolytic fragments. Blood 1993; 81: 745-751
  • 14 Phillips DR, Jennings LK, Edwards HE. Identification of membrane proteins mediating the interaction of human platelets. J Cell Biol 1980; 86: 77-86
  • 15 Laemmli VK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
  • 16 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354
  • 17 L’Ecuyer TJ, Fulton AB. Specific and quantitative immunoprecipitation of tropomyosin and other cytoskeletal proteins by magnetic separation. Bio Techniques 1993; 14: 436-441
  • 18 Beardsley D, Speigel J, Jacobs M, Handin R, Lux S. Platelet membrane glycoprotein Ilia contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias. J Clin Invest 1984; 73: 1701-1707
  • 19 Pfueller SL, Logan D, Trans TT, Bilston RA. Naturally occurring human antibodies to intracellular and cytoskeletal components of human platelets. Clin Exp Immunol 1990; 79: 367-373
  • 20 Giometti CS, Anderson NL. Tropomyosin heterogeneity in human cells. J Biol Chem 1984; 259: 14113-14120
  • 21 Fox JEB. The platelet cytoskeleton. In: Thrombosis and Haemostasis Ver-straete M, Vermylen J, Lijnen HR, Amout J. eds International Society on Thrombosis and Haemostasis and Leuven, University Press; Leuven: 1987: 175-225
  • 22 Dighiero G, Guilbert B, Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. II, High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies. J Immunol 1982; 128: 2788-2792
  • 23 Kaise S, Yasuda T, Kasukawa R, Nishimaki T, Watarai S, Tsumita T. Antiglycolipid antibodies in normal and pathologic human sera and synovial fluids. Vox Sang 1985; 49: 292-300
  • 24 Underwood JR, Pedersen JS, Chalmers PJ, Toh BH. Hybrids from normal, germ free, nude and neonatal mice produce monoclonal autoantibodies to eight different intracellular structures. Clin Exp Immunol 1985; 60: 417-426
  • 25 Jenkins CSP, Maimon J, Puszkin EG. Platelet cytoskeleton: immunofluorescence studies on thrombin-activated platelets. J Lab Clin Med 1984; 104: 563-573